Cargando…

Derivation and validation of the J-CTO extension score for pre-procedural prediction of major adverse cardiac and cerebrovascular events in patients with chronic total occlusions

We developed a prediction model of long-term risk after percutaneous coronary intervention (PCI) for coronary chronic total occlusion (CTO) based on pre-procedural clinical information. A total of 4,139 eligible patients, who underwent CTO-PCI at 52 Japanese centers were included. Specifically, 1,90...

Descripción completa

Detalles Bibliográficos
Autores principales: Ebisawa, Soichiro, Kohsaka, Shun, Muramatsu, Toshiya, Kashima, Yoshifumi, Okamura, Atsunori, Yamane, Masahisa, Sakurada, Masami, Matsuno, Shunsuke, Kijima, Mikihiro, Habara, Maoto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7485776/
https://www.ncbi.nlm.nih.gov/pubmed/32915843
http://dx.doi.org/10.1371/journal.pone.0238640
_version_ 1783581212659417088
author Ebisawa, Soichiro
Kohsaka, Shun
Muramatsu, Toshiya
Kashima, Yoshifumi
Okamura, Atsunori
Yamane, Masahisa
Sakurada, Masami
Matsuno, Shunsuke
Kijima, Mikihiro
Habara, Maoto
author_facet Ebisawa, Soichiro
Kohsaka, Shun
Muramatsu, Toshiya
Kashima, Yoshifumi
Okamura, Atsunori
Yamane, Masahisa
Sakurada, Masami
Matsuno, Shunsuke
Kijima, Mikihiro
Habara, Maoto
author_sort Ebisawa, Soichiro
collection PubMed
description We developed a prediction model of long-term risk after percutaneous coronary intervention (PCI) for coronary chronic total occlusion (CTO) based on pre-procedural clinical information. A total of 4,139 eligible patients, who underwent CTO-PCI at 52 Japanese centers were included. Specifically, 1,909 patients with 1-year data were randomly divided into the derivation (n = 1,273) and validation (n = 636) groups. Major adverse cardiac and cardiovascular event (MACCE) was the primary endpoint, including death, stroke, revascularization, and non-fatal myocardial infarction. We assessed the performance of our model using the area under the receiver operating characteristic curve (AUC) and assigned a simplified point-scoring system. One-hundred-thirty-eight (10.8%) patients experienced MACCE in the derivation cohort with hemodialysis (HD: odds ratio [OR] = 2.55), left ventricular ejection fractions (LVEF) <35% (OR = 2.23), in-stent occlusions (ISO: OR = 2.27), and diabetes mellitus (DM: OR = 1.72). The AUC of the derivation model was 0.650. The model’s performance was similar in the validation cohort (AUC, 0.610). When assigned a point for each associated factor (HD = 3, LVEF <35%, ISO = 2, and DM = 1 point), the average predicted versus the observed MACCE probability using the Japan-CTO extension score for the low, moderate, high, and very high risk groups was 8.1% vs. 7.3%, 16.9% vs. 15.9%, 22.0% vs. 26.1%, and 56.2% vs. 44.4%, respectively. This novel risk model may allow for the estimation of long-term risk and be useful in disseminating appropriate revascularization procedures.
format Online
Article
Text
id pubmed-7485776
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-74857762020-09-21 Derivation and validation of the J-CTO extension score for pre-procedural prediction of major adverse cardiac and cerebrovascular events in patients with chronic total occlusions Ebisawa, Soichiro Kohsaka, Shun Muramatsu, Toshiya Kashima, Yoshifumi Okamura, Atsunori Yamane, Masahisa Sakurada, Masami Matsuno, Shunsuke Kijima, Mikihiro Habara, Maoto PLoS One Research Article We developed a prediction model of long-term risk after percutaneous coronary intervention (PCI) for coronary chronic total occlusion (CTO) based on pre-procedural clinical information. A total of 4,139 eligible patients, who underwent CTO-PCI at 52 Japanese centers were included. Specifically, 1,909 patients with 1-year data were randomly divided into the derivation (n = 1,273) and validation (n = 636) groups. Major adverse cardiac and cardiovascular event (MACCE) was the primary endpoint, including death, stroke, revascularization, and non-fatal myocardial infarction. We assessed the performance of our model using the area under the receiver operating characteristic curve (AUC) and assigned a simplified point-scoring system. One-hundred-thirty-eight (10.8%) patients experienced MACCE in the derivation cohort with hemodialysis (HD: odds ratio [OR] = 2.55), left ventricular ejection fractions (LVEF) <35% (OR = 2.23), in-stent occlusions (ISO: OR = 2.27), and diabetes mellitus (DM: OR = 1.72). The AUC of the derivation model was 0.650. The model’s performance was similar in the validation cohort (AUC, 0.610). When assigned a point for each associated factor (HD = 3, LVEF <35%, ISO = 2, and DM = 1 point), the average predicted versus the observed MACCE probability using the Japan-CTO extension score for the low, moderate, high, and very high risk groups was 8.1% vs. 7.3%, 16.9% vs. 15.9%, 22.0% vs. 26.1%, and 56.2% vs. 44.4%, respectively. This novel risk model may allow for the estimation of long-term risk and be useful in disseminating appropriate revascularization procedures. Public Library of Science 2020-09-11 /pmc/articles/PMC7485776/ /pubmed/32915843 http://dx.doi.org/10.1371/journal.pone.0238640 Text en © 2020 Ebisawa et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Ebisawa, Soichiro
Kohsaka, Shun
Muramatsu, Toshiya
Kashima, Yoshifumi
Okamura, Atsunori
Yamane, Masahisa
Sakurada, Masami
Matsuno, Shunsuke
Kijima, Mikihiro
Habara, Maoto
Derivation and validation of the J-CTO extension score for pre-procedural prediction of major adverse cardiac and cerebrovascular events in patients with chronic total occlusions
title Derivation and validation of the J-CTO extension score for pre-procedural prediction of major adverse cardiac and cerebrovascular events in patients with chronic total occlusions
title_full Derivation and validation of the J-CTO extension score for pre-procedural prediction of major adverse cardiac and cerebrovascular events in patients with chronic total occlusions
title_fullStr Derivation and validation of the J-CTO extension score for pre-procedural prediction of major adverse cardiac and cerebrovascular events in patients with chronic total occlusions
title_full_unstemmed Derivation and validation of the J-CTO extension score for pre-procedural prediction of major adverse cardiac and cerebrovascular events in patients with chronic total occlusions
title_short Derivation and validation of the J-CTO extension score for pre-procedural prediction of major adverse cardiac and cerebrovascular events in patients with chronic total occlusions
title_sort derivation and validation of the j-cto extension score for pre-procedural prediction of major adverse cardiac and cerebrovascular events in patients with chronic total occlusions
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7485776/
https://www.ncbi.nlm.nih.gov/pubmed/32915843
http://dx.doi.org/10.1371/journal.pone.0238640
work_keys_str_mv AT ebisawasoichiro derivationandvalidationofthejctoextensionscoreforpreproceduralpredictionofmajoradversecardiacandcerebrovasculareventsinpatientswithchronictotalocclusions
AT kohsakashun derivationandvalidationofthejctoextensionscoreforpreproceduralpredictionofmajoradversecardiacandcerebrovasculareventsinpatientswithchronictotalocclusions
AT muramatsutoshiya derivationandvalidationofthejctoextensionscoreforpreproceduralpredictionofmajoradversecardiacandcerebrovasculareventsinpatientswithchronictotalocclusions
AT kashimayoshifumi derivationandvalidationofthejctoextensionscoreforpreproceduralpredictionofmajoradversecardiacandcerebrovasculareventsinpatientswithchronictotalocclusions
AT okamuraatsunori derivationandvalidationofthejctoextensionscoreforpreproceduralpredictionofmajoradversecardiacandcerebrovasculareventsinpatientswithchronictotalocclusions
AT yamanemasahisa derivationandvalidationofthejctoextensionscoreforpreproceduralpredictionofmajoradversecardiacandcerebrovasculareventsinpatientswithchronictotalocclusions
AT sakuradamasami derivationandvalidationofthejctoextensionscoreforpreproceduralpredictionofmajoradversecardiacandcerebrovasculareventsinpatientswithchronictotalocclusions
AT matsunoshunsuke derivationandvalidationofthejctoextensionscoreforpreproceduralpredictionofmajoradversecardiacandcerebrovasculareventsinpatientswithchronictotalocclusions
AT kijimamikihiro derivationandvalidationofthejctoextensionscoreforpreproceduralpredictionofmajoradversecardiacandcerebrovasculareventsinpatientswithchronictotalocclusions
AT habaramaoto derivationandvalidationofthejctoextensionscoreforpreproceduralpredictionofmajoradversecardiacandcerebrovasculareventsinpatientswithchronictotalocclusions